Capability of Various Cytokines to Induce Quiescent Myeloid Leukemia Cells to the Proliferative Stage

References

• Kufe D. W., Spriggs D. R. Biochemical and cellular pharmacology of cytosine arabinoside. Semin Oncol 1985; 12: 34–48
   PubMed Web of Science ®Google Scholar
• Tewey K. M., Lowe T. C., Yang L., Halligan B. D., Liu L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase-II. Science 1984; 226: 466–468
   PubMed Web of Science ®Google Scholar
• Sullivan D. M., Gillison B. S., Hodges P. K., Smallwood-Kentro S., Ross W. E. Proliferation dependence of topoisomerase II medicated drug action. Biochemistry 1986; 25: 2248–2256
   PubMed Web of Science ®Google Scholar
• Vellenga E., Ostapovic D., O'Rourke B., Griffin J. D. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1987; 1: 584–589
   PubMed Web of Science ®Google Scholar
• Kellecher C., Miyauchi J., Wong G., Clark S., Minden M. D., McCulloch E. A. Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blastic cell of acute myloblastic leukemia. Blood 1987; 69: 1498–1503
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Kelleher C. A., Yang Y. C., Wong G. G., Clark S. C., Minden M. D., Minkin S., McCulloch E. A. The effect of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blastic cells of acute myeloblasts leukemia maintained in short-term suspension culture. Blood 1987; 70: 657–663
   PubMed Web of Science ®Google Scholar
• Loewenberg B., Salem M., Delwel R. Effects of recombinant proliferation and maturation of human AML in vitro. Blood Cells 1988; 14: 539–549
   PubMedGoogle Scholar
• Budel L. M., Touw I. P., Delwel R., Clark S. C., Loewenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulation factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 1989; 74: 565–571
   PubMed Web of Science ®Google Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Steven C., Lowenberg G., Steven C. Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture systems. Blood 1988; 11: 1944–1949
   Google Scholar
• Giangaspero F., Doglioni C., Rivano M. T., Pileri S., Gerdes J., Stain H. Growth fraction in human brain tumors defined by monoconal antibody Ki-67. Acta Neuropathol 1987; 74: 179–183
   PubMed Web of Science ®Google Scholar
• Vielh P., Chevillard S., Mosseri V., Donatini B., Magdelenat H. Ki-67 index and S-phase fraction in human breast carcinomas. Comparison and correlation with prognostic factors. Am J Clin Pathol 1990; 94: 681–686
   PubMed Web of Science ®Google Scholar
• Okamura K., Miyake K., Kosikawa T., Asai J. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990; 144: 875–878
   PubMed Web of Science ®Google Scholar
• Hall P. A., Richards M. A., Gregory W. M., D'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of a Ki-67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223–235
   PubMed Web of Science ®Google Scholar
• Shirono K., Hattori T., Takatsuki K. Prognostic usefulness of Ki-67 antigen expression in adult T-cell leukemia. The Lancet 1989; 28: 1044
   Google Scholar
• Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated cell proliferation. Int J Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar
• Gerdes J., Lemke H., Baisch H., Wacker H., Schwab U., Stain H. Cell cycle analysis of a proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 (1984). J Immunol 1984; 133: 1710–1715
   PubMed Web of Science ®Google Scholar
• Lopez F., Belloc F., Lacombe F., Dumain P., Reiffers J., Bernard P., Boisseau M. R. Modalities of sythesis of Ki-67 antigen during the stimulation of lymphocytes. Cytometry 1991; 12: 42–49
   PubMedGoogle Scholar
• Landberg G., Tan E. M., Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear anti-gen/cyclin and Ki-67 antigen: A new view of the cell cycle. Exp Cell Res 1990; 187: 111–118
   PubMed Web of Science ®Google Scholar
• Verheijen R., Kuijpers H., Schlingemann R., Boehmer A., Driel R., Breakenhoff G., Ramaekers F. Ki-67 detects a nuclear matrix-assoxiated proliferation-related antigen. J cell Science 1989; 92: 123–130
   PubMed Web of Science ®Google Scholar
• Verheijen R., Kuijpres H., Driel R., Beck J., Dierendonck J., Breakenhoff G., Ramaekers F. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. J. cell Science 1989; 92: 531–540
   PubMed Web of Science ®Google Scholar
• Gerdes J., III, Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H. D. Immunobiochemical and molecular biologic characterization of the cells proliferation-associated nuclear antigen that is defined by Monoclonal antibody Ki-67. Am. J Pathol 1991; 138: 867–873
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z., Evenson D. P., Staiano-Coico L., Sharpless T., Melamed M. R. Relationship between RNA content and progression of lymphocytes through the S phase of the cell cycle. Proc Natl Acad Sci 1979; 76: 358–363
   PubMed Web of Science ®Google Scholar
• Andreeff M., Assing G., Cirrincione C. Prognostic value of DNA/RNA flow cytometry imn myeloblasts and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multivariate analysis. Ann NY Acad Sci 1984; 468: 387–406
   Web of Science ®Google Scholar
• Kurki P., Lotz M., Ogawa K., Tan M. E. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987; 138: 4114–4119
   PubMed Web of Science ®Google Scholar
• Keim D., Hailat N., Hodge D., Hanash M. Proliferating cell nuclear antigen expression in childhood acute leukemia. Blood 1990; 76: 985–990
   PubMed Web of Science ®Google Scholar
• Tafuri A., Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990; 4: 826–834
   PubMed Web of Science ®Google Scholar
• Lista P., Porcu P., Avanzi G. C., Pegoraro L. Interleukin-3 enhances the cytotoxic activity of 1-beta-d arabinofuranosylcytosine (ara-c) on acute myeloblastic leukemia (AML) cells. Br J Haematol 1988; 69: 121–123
   Web of Science ®Google Scholar
• Cannistra S. A., Groshek P., Griffin J. D. Granulocyte-macrophage-colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blastic crisis of chronic myeloid leukemia. Leukemia 1989; 3: 328–334
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Touwl I., Mohmoud L., Lowenberg B. Human AML colony growth in serum-free-culture. Leuk Res 1988; 12: 157–163
   PubMed Web of Science ®Google Scholar
• Bettelheim P., Volent P., Andreeff M., Tafuri A., Haimi J., Gorischek C., Muhm M., Sillaber C. H., Haas O., Vieder L., Maurer D., Scholz G., Speiser W., Geissler K., Kier P., Hinterberger W., Lechner K. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991; 77: 700–711
   PubMed Web of Science ®Google Scholar